Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001123292-24-000398·Mellon James
Schedule 13D ownership disclosure
PORTAGE BIOTECH INC
Ordinary Shares, No Par Value · CUSIP: G7185A136
Event date: 2020-06-16
- Filing-level shares
- 154,673
- Percent of class
- 13.8%
- Mellon JamesReported CIK 0001727650
Shares: 154,673 · Class: 13.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-24-000398
- Form type
- SCHEDULE 13D/A
- Filer
- Mellon James
- CIK
- CIK 1727650
- Filed
- Dec 19, 2024
- Reporting period
- Jun 16, 2020
- Description
- Schedule 13D beneficial ownership